NCT04354701View on ClinicalTrials.gov

COVID-19 and Cancer Consortium Registry

Active, not recruitingOBSERVATIONAL
Enrollment

19,275

Participants

Timeline

Start Date

March 17, 2020

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
COVID-19Invasive Malignancy (Any Type)
Interventions
OTHER

Web-based REDCap survey

The survey takes approximately 5-10 minutes to complete and includes five parts: 1) basic demographics about the patient, including performance status and comorbidities; 2) initial COVID-19 diagnosis and clinical course; 3) cancer and cancer treatment details; 4) respondent details; 5) long-term COVID-19 outcomes.

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt-Ingram Cancer Center

OTHER